%0 Journal Article
%@ 2562-0959
%I JMIR Publications
%V 7
%N 
%P e53792
%T Online Patient Attitudes Toward Cutaneous Immune-Related Adverse Events Attributed to Nivolumab and Pembrolizumab: Sentiment Analysis
%A Powers,Camille M
%A Yang,Andrew K
%A Verma,Hannah
%A Orloff,Jeremy
%A Piontkowski,Austin J
%A Gulati,Nicholas
%+ Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5th Floor, 5 E 98th Street, New York, NY, 10029, United States, 1 212 241 9728, nicholas.gulati@mssm.edu
%K immune checkpoint inhibitor
%K immunotherapy
%K pembrolizumab
%K nivolumab
%K cutaneous immune-related adverse event
%K medical dermatology
%K oncology
%K sentiment analysis
%D 2024
%7 2.5.2024
%9 Research Letter
%J JMIR Dermatol
%G English
%X 
%M 38696235
%R 10.2196/53792
%U https://derma.jmir.org/2024/1/e53792
%U https://doi.org/10.2196/53792
%U http://www.ncbi.nlm.nih.gov/pubmed/38696235